Obesity drugmaker Novo Nordisk posts strong profit
Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted on Wednesday (Nov ...
Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted on Wednesday (Nov ...
RUSSIA’S oil producers Rosneft and Lukoil will sharply cut oil exports from the Black Sea port of Novorossiisk in July, ...
Novo Nordisk plans to invest US$4.1 billion in another US factory, ploughing more money into its biggest market amid rising ...
Novo Nordisk said on Tuesday (Jun 25) its popular weight-loss drug Wegovy has been approved in China, paving the way ...
Danish pharmaceutical giant Novo Nordisk reported more soaring profits on Thursday (May 2) thanks to the popularity of anti-diabetes and ...
NOVO Nordisk Fonden, the enterprise foundation behind Novo Nordisk, will work with Nvidia to build a supercomputer in Denmark to ...
THE US Food and Drug Administration approved Novo Nordisk’s weight-loss drug Wegovy on Friday (Mar 8) for lowering the risk ...
NOVO Nordisk’s head of development on Friday (Mar 8) told Reuters he was very comfortable the drugmaker would be able ...
EUROPE’S main index leapt on Thursday, after the European Central Bank kept rates steady on signs of cooling inflation and as Novo ...
In response to increasing pressure over high drug prices, Denmark-based pharmaceutical company Novo Nordisk has announced a reduction of up ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2025 Forbes 40under40. All Rights Reserved.